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cis-Platinum compounds, which are used in cancer chemotherapy, are thought to exert their effect by
damaging DNA. It is known that this damage is partially repaired in Escherichia coli. Using cis-Pt-treated
pBR322 DNA as a probe, we investigated the role of nucleotide excision repair in the removal of Pt-DNA
adducts. We found that the nucleotide excision pathway was the major mechanism for repairing Pt adducts in
transforming plasmid DNA but that a recA-dependent pathway also contributed to plasmid survival. When
cis-Pt-damaged pBR322 was treated with the purified nucleotide excision enzyme ABC excinuclease in vitro, a
fraction of the adducts was removed by the enzyme; this removal resulted in a corresponding increase in
transformation efficiency.
cis-Platinum complexes are potent antitumor agents (18)
that are being used in treating certain human cancers with
considerable success (see reference 12 for a recent review).
These agents are also toxic to Escherichia coli (1), and it has
been demonstrated that E. coli cells deficient in repairing UV
damage (recA or uvrA) are also deficient in repairing the
damage caused by cis-platinum(II)diamminodichloride (cis-
DDP), suggesting that the same repair mechanisms are
acting on DNA adducts caused by both agents (1).
Although it is generally accepted that the target of the
cytotoxic effects of cis-DDP and its second-generation de-
rivatives, such as cis-1,2-diaminocyclohexyldichloro-
platinum(II) [(cis-DACH)PtClj2, is DNA, there is no consen-
sus as to which type of DNA adduct is responsible for
lethality. These drugs react mainly with N7 of guanine and
produce either a monofunctional adduct or a bidentate
chelate. The bidentate adducts can be in the form of intra- or
interstrand cross-links (16). The fact that the trans isomer,
which is capable of forming monoadducts as well as
interstrand cross-links (16, 20) but not intrastrand cross-
links, is therapeutically ineffective and that the number of
interstrand cross-links does not correlate with cytotoxicity
in resistant lines of mouse L1210 cells (29) suggests that
interstrand cross-links are not the cytotoxic lesions. How-
ever, direct evidence for the lethality of various adducts is
lacking; furthermore, it has been recently found that cis-
Pt(II) can cross-link two adjacent Gs as well as Gs separated
by a third base in the GpNpG sequence (5), making a direct
correlation between one type of adduct and lethality more
difficult. Also, most methods that aim at quantitating the
various Pt(II) adducts involve harsh and sometimees lengthy
treatments (4, 5, 10) which may cause secondary Pt(II)
reactions, resulting in isolation and identification of adducts
that are originally present in low levels or are not present at
all.
We have previously demonstrated that ABC excision
nuclease, which is responsible for initiating nucleotide exci-
sion repair, acts on cis-Pt(II)-damaged DNA in vitro, and
based on findings about the action mechanism of the enzyme
on UV-irradiated DNA, we have suggested that the enzyme
removes Pt(II) mono-and diadducts by cutting on both sides
of the damaged bases, thus producing an oligonucleotide 12
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to 13 bases in length carrying the Pt adduct (26). Since these
oligonucleotides can be separated from the bulk ofDNA and
analyzed for their adduct composition, the enzyme provides
a direct way to measure the relative importance of various
adducts. This paper reports the results of our initial studies
with this system and reveals certain interesting aspects of
cis-Pt(II)-DNA adducts. We found that the lethality of
Pt-DNA adducts could be increased by further incubation of
the complexes and that cis-Pt-damaged plasmid DNA was
repaired primarily by nucleotide excision and secondarily by
postreplication-recombination repair. However, even in
cells deficient in both repair mechanisms, 1.7 adducts per
molecule were required per lethal hit, suggesting either that
some of the cis-Pt adducts are not an obstacle to plasmid
DNA replication or that a third repair mechanism contrib-
utes to the removal of cis-Pt adducts. When cis-Pt-damaged
DNA was treated with purified ABC excinuclease in vitro
and then used to transform E. coli recA uvrA cells, we found
that the enzyme removed the adducts from plasmid DNA
and that there was a corresponding increase in its transfor-
mation efficiency. This finding strongly suggests that the
majority of ABC nuclease-removed DNA adducts are lethal
for DNA replication and, therefore, that analysis of the
removed adducts may provide direct evidence of the identity
of cytotoxic DNA adducts produced by cis-Pt(II) com-
pounds.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli K-12 AB1157 (recA+
uvrA+), AB2463 (recA13), AB1886 (uvrA6), and CSR603
(recAl uvrA6) were obtained from B. J. Bachmann,
Escherichia coli Genetic Stock Center, Yale University, New
Haven, Conn. The pBR322 plasmid (4,363 base pairs) used in
our studies has been described previously (2). The cells were
routinely grown in Luria broth, and pBR322 transformants
were selected on Luria agar containing 20 jig of tetracycline
per ml. Plasmid DNA and frozen competent cells were
prepared by standard procedures. For transformation, 10 to
25 ,ul ofDNA in Tris hydrochloride 10 mM, pH 7.4-NaCl (10
mM)-EDTA (1 mM) was added to 300 IlI of competent cells.
The mixture was kept on ice for 50 min and heat shocked at
42°C for 2 min; after the addition ofLuria broth, the cells were
incubated in a 37°C shaker for 2 h before plating onto selective
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medium. The transformation frequency varied linearly with
the amount of DNA used in our experiments (<100 ng), and
it ranged from about 1 x 105 transformants per jig for strains
AB2463 and CSR603 to 4 x 105 transformants per ,ug for
strains AB1157 and AB1886. Competency showed some
variability from batch to batch, and therefore, all points of a
plasmid survival experiment were obtained with the same
batch of competent cells.
Preparation of radiolabeled (cis-DACH)PtC12. [4,5-3H]cis-
1,2-diaminocyclohexane was obtained from the
Radiosynthesis Laboratory of Research Triangle Institute,
Research Triangle Park, N.C. The compound was prepared
by catalytic reduction of cis-84-1,2-diaminocyclohexane with
tritium gas over 10% palladium per liter. [4,5-3H]cis-1,2-
diaminocyclohexanedichloroplatinum(II) [3H(cis-DACH)
PtCl2] was prepared by reacting the [4,5-3H]cis-diamino-
cyclohexane with K2PtCl4 for 3 h in water at room temnper-
ature. The final compound was purified by recrystallization
from water and dried in a vacuum at 80°C. The final specific
activity was 267 mCi/mmol, and purity was greater than 95%
as judged by reverse-phase high-pressure liquid chromatog-
raphy (I. Husain, S. G. Chaney, and A. Sancar, manuscript
in preparation).
Preparation of ABC excinuclease. The subunits UvrA,
UvrB, and UvrC were prepared, by a modification of the
method of Sancar and Rupp (26), to apparent homogeneity
as tested by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis. Our purified A and C subunits contained
some nonspecific endonuclease activity as measured by the
incision assay (see below) of superhelical DNA; however,
when the excision assay was used as the criterion for purity
(see below), none of the subunits removed cis-Pt adducts
from the DNA. The adducts were removed, however, when
all three subunits were present in the reaction mixture
simultaneously.
Treatment of pBR322 with 3H(cis-DACH)PtC12 in vitro.
3H(cis-DACH)PtCl2 was dissolved in 0.15 M NaCl and
added to pBR322 to obtain final concentrations of 14 ,ug/ml
for DNA and 50 ,uM for the drug in a reaction mixture that
contained Tris hydrochloride (1 mM, pH 7.4), NaCl (25
mM), and EDTA (0.1 mM). The mixture was incubated at
23°C, samples were taken at time intervals, and the reaction
was stopped by adding NaCl to a concentration of 0.5 M.
The unincorporated drug was removed by dialyzing the
samples at 4°C against 0.5 M NaCl for 4 h followed by
overnight dialysis at 4°C against Tris hydrochloride (10 mM,
pH 7.4)-NaCl (10 mM)-EDTA (1 mM). The average number
of adducts per plasmid molecule was determined by measur-
ing the radioactivity in each sample with liquid scintillation
counter (LKB Instruments, Inc., Rockville, Md.) and mea-
suring the plasmid concentration by optical density with an
extinction coefficient of 20 M` cm-1 at 260 nm and an Mr of
2.88 x 106 for pBR322. One reason for using (cis-
DACH)PtCl2 in these studies was that it can be radiolabeled
to form a relatively stable, isotope-containing compound,
unlike cis-dichlorodiamine platinum. The adducts of the
latter must be quantitated with atomic absorption spectrom-
etry whose sensitivity is about an order of magnitude lower
than that of our method.
Repair of cis-platinum-damaged plasmid in vivo and in
vitro. To determine the effects of various E. coli DNA repair
systems on plasmid DNA, E. coli strains of different repair
capabilities were transformed with pBR322 containing 1 to
10 (cis-DACH)Pt-DNA adducts per molecule, and the sur-
vival of transforming efficiency relative to untreated DNA
was calculated. The survivals reported are the averages
obtained from three experiments. For each point, the varia-
tion was less than 10% of the mean.
The platinated DNA was repaired in vitro by incubating it
with ABC excinuclease in a 50-pdl reaction mixture contain-
ing Tris hydrochloride (50 mM, pH 7.5), KCl (100 mM),
MgCl2 (10 mM), ATP (2 mM), dithiothreitol (5 mM), bovine
serum albumin (100 jig/ml), pBR322 DNA (0.27 pmol [con-
taining an average of either 12.5 or 10.7 adducts per mole-
cule]) and UvrA, B, and C proteins at 0.44, 0.6, and 0.6
pmol, respectively. The reaction mixtures were incubated at
23°C for 3, 7, and 30 min, and the reaction was stopped by
adding EDTA to a concentration of 20 mM. The reaction
products were analyzed on agarose gels and by transforma-
tion. To analyze the DNA for its adduct content, sodium
dodecyl sulfate, bromophenol blue, and glycerol were added
to the samples to final concentrations of 0.5, 0.05, and 10%,
respectively, and the samples were heated at 65°C for 5 min
and loaded onto a 1% agarose gel. After the run, the gel was
stained with ethidium bromide, the bands corresponding to
superhelical and open circular DNA were cut out, and the
radioactivity in each band was determined as described
previously (23). From the decrease in total radioactivity in
superhelical plus open circular DNA, the remaining average
number of adducts per DNA molecule was calculated. We
named this assay the excision assay to differentiate it from
the incision assay which we have used previously and which
relies on the fraction of superhelical DNA remaining in the
reaction mixture to quantitate the number of cuts made by
ABC excinuclease (23). Although the incision assay is more
sensitive, it is not reliable when more than five cuts per
molecule are made (less than 0.67% ofDNA is superhelical);
also, it is subject to interference by nonspecific endonucle-
ases. The excision assay, on the other hand, is specific for
ABC nuclease and can reliably measure the removal of any
number of adducts, provided that the adducts are made with
a compound of relatively high specific activity. To measure
the biological repair of ABC excinuclease-treated DNA, we
used the transformation assay as follows: the enzyme-
treated samples were extracted with phenol, and the DNA
was precipitated with ethanol and then suspended in Tris (10
mM, pH 7.4)-NaCl (10 mM)-EDTA (1 mM); 50 to 80 ng of
this suspension was used for transforming E. coli CSR603
(recA uvrA). From the increase in transforming efficiency as
a result of nuclease treatment and the known survival curve
of pBR322 on this strain, the number of adducts repaired was
calculated.
RESULTS
Formation of DNA adducts by (cis-DACH)PtC12 in vitro.
(cis-DACH)PtCl2 is a second-generation antineoplastic plat-
inum compound which is effective against the mouse
L1210/DDP cell line that is resistant to the traditional che-
motherapeutic Pt compound cis-Pt(NH3)2Cl2; therefore, (cis-
DACH)PtCl2 may be advantageous in cancer chemotherapy
over the diaminodichloro- form (3). The cause of the differ-
ential effects of the two drugs is not known. However, it has
been reported that they have similar reactivities (16), since
the carrier ligand (diaminocyclohexyl or NH3) has little
effect on the leaving ligand (Cl in both cases). To test the
reactivity of (cis-DACH)PtCl2 towards DNA in vitro, we
incubated the radiolabeled drug with pBR322 and measured
the adduct formation as a function of time (Fig. 1). After an
inital lag of about 10 min, adducts were formed at a rate of
about 0.12 adduct per min under our experimental condi-
tions. The initial lag was probably due to the time required
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for the formation of aquated forms of the drug, as it is known
that these are the reactive species (16). The kinetics shown
in Fig. 1 are similar to those we obtained with cis-
Pt(NH3)2CI2, and in both cases, the addition of NaCl to a
concentration of 0.5 M completely stopped the reaction
without an effect on the adducts already formed (data not
shown).
Survival of (cis-DACH)PtCI2-damaged plasmid. The effect
of Pt-base adducts on DNA replication in E. coli was studied
by the standard E. coli transformation assay. When E. coli
CSR603 (recA uvrA), which is deficient in the two major
repair pathways acting on Pt adducts (1), was the host, the
results shown in Fig. 2 were obtained. If the DNA was used
immediately after the removal of unincorporated drug, two
adducts per molecule were required per lethal hit. However,
if the DNA, after the removal of unincorporated drug by
dialysis, was incubated at 37°C for 30 h before transforma-
tion, 1.7 adducts per molecule constituted a lethal hit. These
results led to the following conclusion. First, since 1.7
adducts per molecule appeared to be the minimum number
corresponding to one lethal hit, either E. coli possessed a
third repair mechanism to eliminate at least certain types of
Pt adducts or its replication machinery could bypass about
50% of Pt adducts. Second, some nonlethal Pt adducts were
converted to lethal ones upon further incubation at 37°C. It
has been observed by Roberts and Frieldos (15) that incu-
bation of platinated DNA at 37°C for 24 h leads to an
increase in the frequency of interstrand cross-links from 0.66
to 3%. However, this observation cannot completely ac-
count for our results, because even if we assume that every
interstrand cross-link was a lethal adduct and that 3% of the
adducts became interstrand cross-links after incubation at
37°C, this would have reduced the number of adducts per
lethal hit from 2 to 1.94, which is higher than the number we
obtained experimentally. Therefore, we favor the interpre-
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FIG. 1. Kinetics of incorporation of [4,5-3H](cis-DACH)Pt(Cl)2
into superhelical pBR322. The drug-to-nucleotide ratio in the reac-
tion mixture was 2.38. The reaction was conducted at 23°C; samples
were taken at time intervals, and the adduct formation was mea-
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FIG. 2. Survival of transforming efficiency of (cis-
DACH)Pt(Cl)2-damaged pBR32 on an E. coli CSR603 (recA uvrA)
host. Symbols: A, the plasmid was used immediately after the
removal of the unincorporated drug by dialysis at 4°C; 0, after the
removal of unincorporated drug, the DNA was incubated at 37°C for
30 h and then used for transformation.
under our incubation conditions were monoadducts, that
prolonged incubation of monoadducts led to formation of
intra- as well as interstrand cross-links, and that the increase
in frequency of intrastrand cross-links was the predominant
contributor to increased lethality.
Effects of nucleotide excision and postreplication-
recombination repair pathways on plasmid survival. The use
of plasmids offers certain advantages in probing cellular
DNA repair systems compared with direct treatment of cells
or an infecting phage with the damaging agents in that any
biological consequence of the treatment is a result of DNA
damage only and reflects the ability of the cell to deal with
that damage. The E. coli transformation assay with plasmid
DNA has been used to probe the repair of this bacterium for
acting on DNA damaged by various agents (13, 17, 22, 24,
25, 27, 30). The survival of (cis-DACH)PtCl2-damaged
pBR322 on E. coli hosts with various repair capabilities is
shown in Fig. 3. In all of these cases, DNA that had been
incubated at 37°C for 30 h after drug treatment was used to
eliminate a possible change in adduct composition because
of prolonged storage in a refrigerator. Indeed, the same
survival curve was obtained for our tester strain, CSR603,
over the 3-week period in which these experiments were
conducted. We found D37 of 1.7, 2.6, 4.8, and 5.5 adducts per
molecule for CSR603 (recA uvrA), AB1886 (recA+ uvrA),
AB2463 (recA uvrA+), and AB1157 (recA+ uvrA+), respec-
tively (Fig. 3). The last number is in reasonable agreement
with the finding that five cis-Pt adducts per phage particle
VOL. 163, 1985
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FIG. 3. Survival of a (cis-DACH)Pt-adducted pBR322 plasmid
on E. coli strains of various repair capabilities. The data points for
CSR603 are taken from Fig. 2. The transformation experiments in all
cases were carried out with DNAs that were incubated at 37°C for 30
h after the incorporation of the drug into the plasmid. Symbols: *,
CSR603 (recA uvrA); A, AB1886 (recA+ uvrA); O, AB2463 (recA
uvrA+); A, AB1157 (recA+ uvrA+).
(four of which were with the nucleic acid) constituted a lethal
hit for the T7 phage (28). From these data it seems clear that
the main repair system removing Pt adducts from DNA was
the nucleotide excision repair. However, it also seems clear
that the RecA+ phenotype contributed significantly to plas-
mid survival. Similar effects have been observed with plas-
mids damaged by UV (17) and N-acetoxy-N-2-acetylamino-
fluorene (N-AAAF) (27), but not with those damaged by
benzo(a)pyrene-7,8-dihydrodiol-9,10-oxide (BPDE) (13). We
compared the survival of plasmid-containing Pt adducts in E.
coli strains of different repair capabilities with survival rates
reported in the literature for other DNA damaging agents
(Table 1). As is apparent from Table 1, cis-Pt adducts were
more like UV- and BPDE-produced adducts with regard to
their lethalities, and they differed significantly from N-
AAAF adducts, which are removed very efficiently by ABC
excinuclease (7, 27, 30). Whether the differences among the
lethalities of BPDE, UV, and cis-Pt adducts are real or an
artifact due to the different sensitivities of the methods used
to determine the number of adducts remains to be seen.
However, it is clear from this table that N-AAAF adducts
are far less lethal than the other three.
Repair of (cis-DACH)PtCI2-damaged DNA in vitro. The
results reported above indicate that ABC excinuclease is
involved in repairing cis-Pt-DNA adducts. If this indeed is
the case, then treatment of platinated DNA with ABC
excinuclease in vitro should result in the removal of the
adducts from the plasmid and in a corresponding increase in
TABLE 1. Survival of plasmids damaged by various agents in
E. coli strains of different repair capabilities
Phenotype of No. of adducts/lethal hita
Ecoli K-12 BPDEb UVc cis-Ptd N-AAAFe
RecA+ UvrA+ 3 5.54 5.5 20
RecA- UvrA+ 3 3.75 4.8 18
RecA+ UvrA- 1 1.48 2.6 5
RecA- UvrA- 1.09 1.7 2
a A lethal hit per molecule reduces the transformation efficiency of plasmid
to 37% as predicted from Poisson distribution of adducts.
b From reference 13. The plasmid used was pK0482, a 4.2-kilobase-pair
derivative of pBR322.
c From reference 17. The plasmid used was NTP16, an 8.8-kilobase-pair
nonconjugative plasmid.
d This study.
' From the data in references 7 and 27. In reference 27, the plasmid was
pKO482, and in reference 7, the plasmid was pBR322. Tang et al. (30)
reported less than two N-AAAF adducts per molecule per lethal hit in uvrA
cells with the 4X174 transfection assay.
the transforming efficiency of the damaged DNA. To repair
the cis-Pt-damaged DNA in vitro, we incubated the modified
DNA (12.5 or 10.7 Pt adducts per pBR322 molecule) with the
enzyme for various time periods. At the end of each period,
part of the reaction mixture was analyzed to measure the
number of adducts removed, and the other part was tested
for biological activity by transforming E. coli CSR603 (recA
uvrA) to tetracycline resistance. We plotted the number of
adducts removed as measured by the transformation assay
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FIG. 4. Removal of cis-Pt adducts from DNA results in biologi-
cal activation of transforming DNA. pBR322 DNA containing cis-Pt
adducts was incubated with ABC excinuclease; the numbers of
adducts removed and the numbers of lesions repaired at various
time points were determined by the exicision assay and transforma-
tion assay, respectively. The data points in this figure were obtained
from two representative experiments with plasmid DNAs that
originally contained 12.5 to 10.7 adducts per molecule. ABC
excinuclease had no effect on the transforming efficiency of undam-
aged DNA (data not shown).
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apparent from Fig. 4, there was a good correlation between
the results obtained with the two assays. The activity
measured by the transformation assay was consistently 20 to
25% lower than that measured by the excision assay. We
think this is because the gapped DNA generated by ABC
nuclease (a 12- to 13-nucleotide gap per adduct removed)
was more susceptible to endonuclease attack upon uptake
than was superhelical or nicked DNA. Whatever the cause
for the relatively small discrepancy between the two assays,
it seems clear from our results that platinated plasmid DNA
could be repaired by ABC excinuclease in vitro.
DISCUSSION
In this paper we report our investigation of the production
of DNA adducts by (cis-DACH)PtCl2 in vitro with pBR322
DNA and the repair of these adducts in E. coli in vivo and by
ABC excinuclease in vitro. Our main findings and conclu-
sions can be summarized as follows.
(i) We used 3H-labeled (267 mCi/mmol) (cis-DACH)PtCl2
in our experiments to monitor the reactivity of this drug with
DNA in vitro. The use of such a highly radioactive com-
pound enabled us to detect the formation of as little as one
adduct per 4,400 base pairs with reasonable accuracy. This
level of detection is far superior to the conventional atomic
absorption spectrometry used in cis-Pt studies. Under our
experimental conditions, (cis-DACH)PtCl2, after an initial
lag, produced DNA adducts at a constant rate over the
duration of the experiment; this rate was similar to the rate
obtained with cis-Pt(NH3)2C12.
(ii) With plasmid DNA treated in vitro with cis-Pt com-
pounds, it should be possible to determine the relative
importance of various adducts in cytotoxicity and to identify
the DNA repair pathways involved in removing these
adducts. We found that 5.5 cis-Pt adducts per transforming
DNA molecule constituted a lethal hit in wild-type E. coli.
This is in reasonable agreement with the four adducts per
molecule per lethal hit found with T7 phage infection (27) but
is considerably lower than the about 20 adducts per molecule
per lethal hit that was found by the transfection assay with
lambda DNA (6). It is possible that in the latter experimental
system, the multiplicity of infection was higher than in the
other two experimental setups, which may allow extensive
recombination and high survival by what might be called a
marker rescue mechanism. In E. coli mutants deficient in
excision repair, 2.6 adducts per molecule constituted a lethal
hit, indicating that nucleotide excision repair is the major
pathway for removing platinum adducts from transforming
plasmid DNA. This finding is in line with the fact that uvrA-
cells are more sensitive to cis-DDP (1) and that cis-DDP-
treated DNA is cut by ABC excinuclease in vitro (26), but it
differs from the results obtained by Munchausen with the
Haemophilus influenzae transformation assay (14). In that
system it was found that transforming DNA treated with
cis-Pt had the same survival on Uvr+ and Uvr- cells. This is
not surprising because the two systems are different in two
important aspects. First, transformation in H. influenzae
involves incorporation of single-stranded DNA into the host
chromosome, whereas the E. coli plasmid transformation
assay depends on establishment of a second replicon in the
host cells. Second, although it is well established that E. coli
ABC excinuclease acts on a wide variety of nucleotide
adducts, it is not clear at present whether the H. influenzae
nuclease encoded by the uvr-J and uvr-2 genes acts on
adducts other than pyrimidine dimers.
Cells carrying mutations at the recA locus repaired the
cis-Pt-damaged plasmid less efficiently than did their recA+
counterparts whether the latter cells were uvr+ or not,
indicating that recA participants in repair pathway that,
although inefficient, is uvrA+ independent. Whether this
repair pathway functions by the classical postreplication-
recombination mechanism (21) is debatable. Similar rela-
tively small effects of recA on plasmid survival have been
observed for UV-damaged or N-AAAF-treated DNAs (17,
27). The plasmid concentrations used in all of these experi-
ments appear to be too low to give rise to double transfor-
mants, which might easily explain the recA effect (11, 31).
However, the usual means of estimating double-transfor-
mation frequency may not actually reflect the fraction of
cells that take up more than one DNA molecule. With a
method developed by Goodgal and Herriott (8), it has been
determined that in E. coli cells rendered competent by the
Mandel-Higa CaCl2 method, only 0.26% of the cells are
competent to be transformed (31). If we assume that only
these cells take up DNA, then under our experimental
conditions the ratio of pBR322 to competent cells is about 6
x 104. As previously argued (31), an average of 6 x 104
molecules of pBR322 per competent cell may need to be
taken up for transformation to be established. If such is the
case, then there would be plenty of opportunities for
recombinational repair of transforming plasmids. However,
such reasoning fails to explain the fact that recA had no
effect on the survival of BPDE-damaged plasmids (13). It is
formally possible that the UvrABC- and RecA-dependent
pathways operate on different specific classes of Pt adducts
of equal lethality but that one type of adduct (repaired by the
recA pathway) is formed to a lesser extent compared with
the adducts repaired by the ABC excinuclease. Further
investigation is needed to clarify this point, but it is worth
mentioning that of the DNA adducts tested by the E. coli
transformation assay, those produced by BPDE seem to be
the most lethal even in wild-type cells (three adducts per
molecule per lethal hit).
While UV- and cis-Pt-produced DNA adducts have similar
lethalities in various E. coli strains, N-AAAF-DNA adducts
seem to be less lethal in all strains tested. The large number
of adducts required to assure lethality in UvrA+ strains (27,
30) is consistent with the idea that these latter adducts are
removed more efficiently by ABC excinuclease. However,
we believe that the adducts are partly removed by sponta-
neous depurination as well, as it is known that the major
N-AAAF adduct, G-C8-AAF, weakens the glycosidic bond
of G (32). This might also explain why two or more N-AAAF
adducts are required per lethal hit in recA- UvrA- cells (7,
27). However, spontaneous depurination cannot be the
explanation for the fact that two adducts per molecule in
freshly treated plasmids and 1.7 adducts per molecule in
posttreatment-incubated plasmids are needed for a lethal hit
by (cis-DACH)PtC12, since the major cis-Pt adducts, the
Pt-G-N7 coordination complexes (mono- or bifunctional)
appear to strengthen the glycosyl bond (9, 32). It is conceiv-
able that approximately 50% of cis-Pt adducts formed in
vitro are monoadducts that either remain so after cellular
uptake or more likely form DNA-Pt-protein cross-links and
that the monoadducts and perhaps the DNA-Pt-protein
cross-links are removed by a DNA glycosylase specific for
these cis-Pt adducts. With respect to monoadducts, current
chemical estimates (4, 5) are much lower than our model
suggests, but all of the analyses to isolate Pt base adducts
involve lengthy incubations which may lead to underestima-
tion of monoadducts. Numerous in vitro and in vivo exper-
iments have demonstrated that rapid formation of DNA-
platinum adducts which can be subsequently converted to
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cross-links (15, 29, 35). Thiourea rescue experiments suggest
that the majority of the platinum adducts formed in short
incubations may be monoadducts, with conversion of the
monoadducts to both intra- and interstrand cross-links oc-
curring over a period of hours (34). This is consistent with
our finding that incubation of our platinated DNA at 37°C
increased the lethality of the adducts. However, even after
30 h of incubation at 37°C, we found 41% of the cis-Pt
adducts to be nonlethal. It is possible that even after such a
treatment, 41% of the Pt-DNA adducts are still in the
monofunctional form and are rapidly removed by a hypo-
thetical glycosylase or are converted to the nonlethal DNA-
Pt-protein cross-links upon entering the cell. The DNA-Pt-
protein cross-links appear to be a major form of platinum
adducts (5, 35) and have apparently little or no toxicity (35).
(iii) (cis-DACH)PtC12-damaged DNA can be efficiently
repaired in vitro by ABC excinuclease. Even though previ-
ous studies have demonstrated that purified ABC
excinuclease cuts cis-platinum-damaged DNA (26), this is
the first demonstration that cutting resulted in the removal of
cis-Pt adducts from DNA and in repair, in a biological sense,
since the transforming efficiency of the nuclease-treated
DNA was increased. The removal of cis-Pt adducts from
DNA led to a parallel decrease in the average number of
lethal hits remaining per molecule. However, the repair
measured by the increase in transformation efficiency corre-
sponded to about 75% of that measured biochemically by our
excision assay. We believe that this discrepancy is due to the
reduced transforming efficiency of gapped DNA as the
removal of cis-Pt DNA adducts creates 12- to 13-nucleotide-
long gaps which are likely to be more susceptible to attack
by nonspecific endonucleases. However, we cannot exclude
the possibility that ABC excinuclease has a slight preference
in removing nonlethal Pt adducts. Analysis of the adduct
composition in total and excised DNA should help in clari-
fying this point.
Finally, although the results presented in this paper,
together with those obtained by Van Houten and Masker
(30a) with benzo[a]pyrene-damaged T7 phage DNA and
partially purified cell extracts of Uvr+ cells, may be consid-
ered as the reconstitution of E. coli nucleotide excision
repair in vitro, it should be pointed out that in our experi-
ments the plasmid DNA, after ABC excinuclease digestion,
was deproteinized by either heating in the presence of
sodium dodecyl sulfate or, phenol extraction before analysis
on agarose gels or by transformation. Thus, even though it is
clear that the enzyme excises an oligonucleotide carrying the
damaged nucleotide(s), it remains to be seen whether it
dissociates from its cutting site (33) at a physiological rate or
whether additional factors (uvrD helicase, DNA polymerase)
are required to facilitate the dissociation. Preliminary exper-
iments indicate that cis-Pt-DNA adducts are removed by
ABC excinuclease only stoichiometrically and that additions
of DNA polymerase I and helicase II (uvrD protein) to the
reaction mixture promote the turnover of the excision nu-
clease.
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